Abstract:Background: Constitutive activation of the ERK pathway, occurring in the vast majority of melanocytic neoplasms, has a pivotal role in melanoma development. Different mechanisms underlie this activation in different tumour settings. The Grey phenotype in horses, caused by a 4.6 kb duplication in intron 6 of Syntaxin 17 (STX17), is associated with a very high incidence of cutaneous melanoma, but the molecular mechanism behind the melanomagenesis remains unknown. Here, we investigated the involvement of the ERK pathway in melanoma development in Grey horses. Methods: Grey horse melanoma tumours, cell lines and normal skin melanocytes were analyzed with help of indirect immunofluorescence and immunoblotting for the expression of phospho-ERK1/2 in comparison to that in non-grey horse and human counterparts. The mutational status of BRAF, RAS, GNAQ, GNA11 and KIT genes in Grey horse melanomas was determined by direct sequencing. The effect of RAS, RAF and PI3K/AKT pathways on the activation of the ERK signaling in Grey horse melanoma cells was investigated with help of specific inhibitors and immunoblotting. Individual roles of RAF and RAS kinases on the ERK activation were examined using si-RNA based approach and immunoblotting. Results: We found that the ERK pathway is constitutively activated in Grey horse melanoma tumours and cell lines in the absence of somatic activating mutations in BRAF, RAS, GNAQ, GNA11 and KIT genes or alterations in the expression of the main components of the pathway. The pathway is mitogenic and is mediated by BRAF, CRAF and KRAS kinases. Importantly, we found high activation of the ERK pathway also in epidermal melanocytes, suggesting a general predisposition to melanomagenesis in these horses. Conclusions: These findings demonstrate that the presence of the intronic 4.6 kb duplication in STX17 is strongly associated with constitutive activation of the ERK pathway in melanocytic cells in Grey horses in the absence of somatic mutations commonly linked to the activation of this pathway during melanomagenesis. These findings are consistent with the universal importance of the ERK pathway in melanomagenesis and may have valuable implications for human melanoma research.

A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse

White horses – non-coding sequences drive premature hair greying and predisposition to melanoma

An intronic copy number variation in Syntaxin 17 determines speed of greying and melanoma incidence in Grey horses

Identification of a melanocyte-specific, microphthalmia-associated transcription factor-dependent regulatory element in the intronic duplication causing hair greying and melanoma in horses

Complex inheritance of melanoma and pigmentation of coat and skin in Grey horses

Copy number expansion of the STX17 duplication in melanoma tissue from Grey horses

Coat color genotypes and risk and severity of melanoma in gray quarter horses

Constitutive activation of the ERK pathway in melanoma and skin melanocytes in Grey horses

Treatment Options for Melanoma of Gray Horses

The equine graying with age mutation of the STX17 gene: A copy number study using droplet digital PCR reveals a new pattern

Hair Graying Regulators Beyond Hair Follicle

Equine Melanocytic Tumors: A Narrative Review

Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma

Melanocortin-1 receptor mutations and pigmentation: Insights from large animals

Synergy Between MC1R and ASIP for Coat Color in Horses (equus Caballus)1.

Frequency of gray coat color in native Chinese horse breeds

A novel DDB2 mutation causes defective recognition of UV-induced DNA damages and prevalent equine squamous cell carcinoma

Reverse genetic screen for loss-of-function mutations uncovers a frameshifting deletion in the melanophilin gene accountable for a distinctive coat color in Belgian Blue cattle.

A missense mutation in damage-specific DNA binding protein 2 is a genetic risk factor for limbal squamous cell carcinoma in horses

A novel nonsense mutation and polymorphisms in the mouse hairless gene.

Melanophilin Polymorphism in Ferrets of Different Color